Evidence map›Paper›PMID 21710395›Full record

ReviewSeminars in reproductive medicine2011

Placental dysfunction and fetal programming: the importance of placental size, shape, histopathology, and molecular composition.

Mark S Longtine, D Michael Nelson

Abstract readReview
In one paragraph

Review in Seminars in reproductive medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A head start: The relationship of placental factors to craniofacial and brain development.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Associations between placental pathology and poor intrauterine growth among a cohort of mother-infant singleton pairs in Leyte, the Philippines.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark S LongtineDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. longtine@wudosis.wustl.edu
D Michael Nelson

Funding

PLACENTAL TROPHOBLAST, EICOSANOIDS, AND PREECLAMPSIAR01HD029190 · NICHD · WASHINGTON UNIVERSITY · PI NELSON, DONALD MICHAEL · 1994 to 2011
$2.3M
NICHD NIH HHS R01 HD029190NICHD NIH HHS R01-HD29190
6 · The paper itself

Abstract

Normal function of the placenta is pivotal for optimal fetal growth and development. Fetal programming commonly is associated with placental dysfunction that predisposes to obstetric complications and suboptimal fetal outcomes. We consider several clinical phenotypes for placental dysfunction that likely predispose to fetal programming. Some of these reflect abnormal development of the chorioallantoic placenta in size, shape, or histopathology. Others result when exogenous stressors in the maternal environment combine with maladaptation of the placental response to yield small placentas with limited reserve, as typical of early-onset intrauterine growth restriction and preeclampsia. Still others reflect epigenetic changes, including altered expression of imprinted genes, altered enzymatic activity, or altered efficiencies in nutrient transport. Although the human placenta is a transient organ that persists only 9 months, the effects of this organ on the offspring remain for a lifetime.

Indexed as

Fetal DevelopmentPlacentationPrenatal Exposure Delayed EffectsAdultAnimalsFemaleFetal Growth RetardationGenomic ImprintingHumansMaleMaternal-Fetal ExchangeOrgan SizePlacentaPlacenta DiseasesPre-EclampsiaPregnancy

Identifiers

PMID21710395
PMCPMC3682832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.